Call Us
+60 10 8808 195
About Us
Meet Our Experts
Dr. James Christopher Obagarasamy, MD, DABRM
Diploma, American Board of Regenerative Medicine (DABRM)
Group CEO & Medical Director, KLEM Group
Dr. James Christopher Obagarasamy is a highly respected physician and leader in the field of regenerative medicine, currently serving as Group CEO and Medical Director of KLEM Group. With a strong clinical foundation and a forward-thinking approach to healthcare, he has played a pivotal role in advancing the integration of regenerative therapies into modern medical practice.
His work focuses on the application of cutting-edge treatments such as stem cell therapy, exosome therapy, and secretome-based solutions, bringing innovation into personalised patient care. Through his leadership, these advanced approaches are delivered with a strong emphasis on precision, safety, and long-term outcomes.
Beyond traditional medicine, Dr. James advocates for a holistic and patient-centred approach, combining scientific innovation with overall wellness. His vision has contributed to establishing KLEM as a recognised centre for advanced therapies aimed at supporting the body’s natural ability to repair, restore, and rejuvenate at the cellular level.
Driven by a passion for medical advancement, Dr. James continues to contribute to the development of next-generation therapies designed to address chronic conditions, enhance recovery, and improve quality of life. His commitment reflects a broader mission to make regenerative medicine more accessible, effective, and impactful for patients seeking sustainable health solutions.
Datuk Dr. Khairul Idzwan Baharin
D.P.S.M, DABRM, MBBS
Founder, Cell Tissue Group
Qualifications & Certifications:
- MBBS (International Medical University – IMU)
- American Academy of Aesthetic Medicine (AAAM)
- Diploma, American Board of Regenerative Medicine (DABRM)
- Certificate in Clinical Wound Care (CCWC)
- SKM3 Aesthetic Cosmetology
Datuk Dr. Khairul Idzwan Baharin is a distinguished medical doctor, biomedical innovator, and certified aesthetic practitioner, widely recognised for his contributions to regenerative medicine and medical technology. As the Founder of Cell Tissue Group, he has been instrumental in advancing solutions within tissue engineering and regenerative healthcare.
With a strong clinical background, his journey into regenerative medicine was shaped by firsthand experience managing complex cases involving severe skin loss and non-healing wounds. These challenges inspired his commitment to developing innovative, patient-focused treatments that address both medical and aesthetic concerns at a deeper, cellular level.
Beyond clinical practice, Datuk Dr. Khairul has dedicated years to research and innovation in aesthetic medicine and wound care technologies. Under his leadership, Cell Tissue Group has expanded significantly, establishing itself as a key player in regenerative medicine solutions.
His achievements have been internationally recognised, including receiving the MEGAGist Award and being honoured as a “Transformer of Excellence” by the U.S. Department of State. This recognition placed him among the top 1% of over 1,500 ventures across 54 countries, reflecting his impact on global medical innovation.
Driven by a vision to transform healthcare, Datuk Dr. Khairul continues to lead advancements in regenerative therapies, focusing on improving patient outcomes, accelerating recovery, and enhancing overall quality of life.
Advancing Regenerative Medicine You Can Trust
ACTERM is dedicated to the advancement of tissue engineering and regenerative medicine through research, precision, and innovation. Our work focuses on developing scientific solutions that support the future of healthcare — moving beyond conventional approaches into next-generation medical possibilities.
We combine advanced technologies, controlled processes, and multidisciplinary expertise to ensure consistency, accuracy, and reliability in everything we do.